Brief: Atea Pharmaceuticals Appoints Howard H. Berman To Board Of Directors And Announces Share Repurchase Program
17/04/2025 12:05
April 17 (Reuters) - Atea Pharmaceuticals Inc AVIR.O: ATEA PHARMACEUTICALS APPOINTS HOWARD H. BERMAN TO BOARD OF DIRECTORS AND ANNOUNCES SHARE REPURCHASE PROGRAM ATEA PHARMACEUTICALS INC: AUTHORIZED REPURCHASE OF UP TO $25 MILLION OF COMPANY'S COMMON STOCK Source text: ID:nGNX7JPgR1 Further company coverage: AVIR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atea Pharmaceuticals
See all newsAtea Pharmaceuticals Q2 loss narrows as HCV trial expenses decline
Atea Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:30 AM